Aurinia Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
The current Aurinia Pharmaceuticals(AUPH) stock price is $15.57, with a market capitalization of 2.05B. The stock trades at a price-to-earnings (P/E) ratio of 27.95.
On 2025-11-12, Aurinia Pharmaceuticals(AUPH) stock moved within a range of $15.40 to $15.99. With shares now at $15.57, the stock is trading +1.1% above its intraday low and -2.6% below the session's peak.
Trading volume for Aurinia Pharmaceuticals(AUPH) stock has reached 860.57K, versus its average volume of 2.7M.
The stock's 52-week range extends from a low of $6.55 to a high of $16.20.
The stock's 52-week range extends from a low of $6.55 to a high of $16.20.
AUPH News
Jefferies upgraded Aurinia Pharmaceuticals (AUPH) to Buy from Hold with a price target of $21, up from $10. The company’s commercial performance with Lupkynis h...
Aurinia Pharmaceuticals recently raised its full-year 2025 revenue and net product sales guidance following strong third-quarter financial results, with total r...
